INS and type 2 diabetes mellitus: While chronic ROS overproduction can cause mitochondrial damage and reduced function in type 2 diabetes [34], short-term HBO treatment of diabetic rodents also increased whole-body insulin sensitivity despite elevated mitochondrial ROS production along with increased mRNA expression of biomarkers of antioxidative defence [35].